Mobile Site ›
Normal View

Test ID: RTRPP
Tubular Reabsorption of Phosphorus, Random

Secondary ID A test code used for billing and in test definitions created prior to November 2011

88546

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Assessing renal reabsorption of phosphorus in a variety of pathological conditions associated with hypophosphatemia including hypophosphatemic rickets, tumor-induced osteomalacia and tumoral calcinosis

 

Adjusting phosphate replacement therapy in severe deficiency states monitoring the renal tubular recovery from acquired Fanconi's syndrome

Profile Information A profile is a group of laboratory tests that are ordered and performed together under a single Mayo Test ID. Profile information lists the test performed, inclusive of the test fee, when a profile is ordered and includes reporting names and individual availability.

Test IDReporting NameAvailable SeparatelyAlways Performed
RTRPTubular Phosp Reabsorption, RandomNoYes
CTURCreatinine ConcYes, (Order CTU)Yes
PHOSPhosphorus (Inorganic), SYesYes
CREA2Creatinine, SYes, (Order CREAZ)Yes

Method Name A short description of the method used to perform the test

RTRP/26605: Calculation

CTUR/24017, CREA2/28266: Enzymatic Colorimetric Assay

PHOS/8408: Photometric, Ammonium Molybdate

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Tubular Phosp Reabsorption, Random

Specimen Type Describes the specimen type needed for testing

Serum
Urine

Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.

Serum and urine are required.

 

Specimen Type: Serum

Collection Container/Tube: Red top or serum gel

Submission Container/Tube: Plastic vial

Specimen Volume: 0.5 mL

Collection Instructions:

1. Fasting.

2. Label specimen as serum.

 

Specimen Type: Urine

Container/Tube: Plastic, 6-mL tube (Supply T465)

Specimen Volume: 5 mL

Collection Instructions:

1. Collect a random urine specimen.

2. No preservative.

3. Label specimen as urine.

Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.

Urine: 1 mL/Serum: 0.25 mL

Reject Due To Identifies specimen types and conditions that may cause the specimen to be rejected

Hemolysis

NA

Lipemia

NA

Icterus

NA

Other

NA

 

Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.

Specimen TypeTemperatureTime
SerumFrozen (preferred)7 days
 Refrigerated 7 days
UrineRefrigerated (preferred)
 Ambient 
 Frozen 

Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

The tubular reabsorption of phosphate (TRP) is the fraction (or percent) of filtered phosphorus that is reabsorbed by renal tubules. Its measurement is useful when evaluating patients with hypophosphatemia. In general, a reduced TRP in the presence of hypophosphatemia is indicative of a renal defect in phosphate reabsorption.

 

The ratio of the maximum rate of tubular phosphate reabsorption to the glomerular filtration rate (TmP/GFR) is considered the most convenient way to evaluate renal phosphate transport and is referred to as the theoretical renal phosphate threshold. This corresponds to the theoretic lower limit of plasma phosphate below which all filtered phosphate would be reabsorbed. Although direct measurements of parathyroid hormone (PTH), which increases renal phosphate excretion have replaced much of the utility of TmP/GFR measurements, it may still be useful in assessing renal reabsorption of phosphorus in a variety of pathological conditions associated with hypophosphatemia.

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

TUBULAR REABSORPTION OF PHOSPHORUS

>80%

(Although, tubular reabsorption of phosphorus levels must be interpreted in light of the prevailing plasma phosphorus and glomerular filtration rate.)

 

TUBULAR MAXIMUM PHOSPHORUS REABSORPTION/GLOMERULAR FILTRATION RATE (TmP/GFR)

2.6-4.4 mg/dL (0.80-1.35 mmol/L)

 

PHOSPHORUS (INORGANIC)

Males

1-4 years: 4.3-5.4 mg/dL

5-13 years: 3.7-5.4 mg/dL

14-15 years: 3.5-5.3 mg/dL

16-17 years: 3.1-4.7 mg/dL

> or =18 years: 2.5-4.5 mg/dL

Reference values have not been established for patients that are <12 months of age.

Females

1-7 years: 4.3-5.4 mg/dL

8-13 years: 4.0-5.2 mg/dL

14-15 years: 3.5-4.9 mg/dL

16-17 years: 3.1-4.7 mg/dL

> or =18 years: 2.5-4.5 mg/dL

Reference values have not been established for patients that are <12 months of age.

 

CREATININE

Males

12-24 months: 0.1-0.4 mg/dL

3-4 years: 0.1-0.5 mg/dL

5-9 years: 0.2-0.6 mg/dL

10-11 years: 0.3-0.7 mg/dL

12-13 years: 0.4-0.8 mg/dL

14-15 years: 0.5-0.9 mg/dL

> or =16 years: 0.8-1.3 mg/dL

Reference values have not been established for patients that are <12 months of age.

Females

12-36 months: 0.1-0.4 mg/dL

4-5 years: 0.2-0.5 mg/dL

6-8 years: 0.3-0.6 mg/dL

9-15 years: 0.4-0.7 mg/dL

> or =16 years: 0.6-1.1 mg/dL

Reference values have not been established for patients that are <12 months of age.

Interpretation Provides information to assist in interpretation of the test results

Interpretation of tubular reabsorption of phosphate (TRP) and TmP/GMR is dependent upon the clinical situation, and should be interpreted in conjunction with the serum phosphorous concentration.

 

TmP/glomerular filtration rate (GFR) is independent of dietary phosphorus intake, tissue release of phosphorus, and GFR.

Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances

No significant cautionary statements

Clinical Reference Provides recommendations for further in-depth reading of a clinical nature

1. Suki WN, Lederer ED, Rouse D: Renal transport of calcium, magnesium, and phosphate. In The Kidney, 6th edition, Edited by B Brenner. WB Saunders Company, 2000, Chapter 12

2. Bijvoet OL: Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate. Clin Sci 1969;37:23-36

3. Walton RJ, Bijvoet OL: Nomogram for derivation of renal threshold phosphate Concentration. Lancet 1975;2:309-310

4. Payne RB: Renal tubular reabsorption of phosphate (TmP/GFR): indications and interpretation. Ann Clin Biochem 1998;35:201-206

Method Description Describes how the test is performed and provides a method-specific reference

Creatinine is performed by the enzymatic method, which is based on the determination of sarcosine from creatinine with the aid of creatininase, creatinase, and sarcosine oxidase. The liberated hydrogen peroxide is measured via a modified Trinder reaction using a colorimetric indicator. Optimization of the buffer system and the colorimetric indicator enables the creatinine concentration to be quantified both precisely and specifically. (Package insert: Roche Diagnostics, Indianapolis IN, 2004)

 

In the phosphorus assay, inorganic phosphorus reacts with ammonium molybdate in an acidic solution to form ammonium phosphomolybdate, which is quantified in the ultraviolet range (340nm). (Package insert: Roche Phosphorus, Roche Diagnostic Corp, Indianapolis, IN)

Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.

Monday through Sunday; Continuously

Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.

Same day/1 day

Specimen Retention Time Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded

See Individual Unit Codes

Performing Laboratory Location The location of the laboratory that performs the test

Rochester

Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.

This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

82565-Creatinine

84100-Phosphorus inorganic (phosphate), serum

84105-Phosphorus inorganic (phosphate), urine

LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.

Result IDReporting NameLOINC Code
CREA2Creatinine, S2160-0
CTURCreatinine Conc35674-1
PHOSPhosphorus (Inorganic), S2777-1
TRATRPIn Process
GFRRRandom TmP/GFRIn Process